BLUEPRINT MEDICINES CORP shareholders Q2 2023

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 221 filers reported holding BLUEPRINT MEDICINES CORP in Q2 2023. The put-call ratio across all filers is 2.57 and the average weighting 0.2%.

BLUEPRINT MEDICINES CORP shareholders Q2 2023
NameSharesValueWeighting ↓
SIMPLEX TRADING, LLC 14,524$9170.00%
Clearstead Trust, LLC 101$4,5440.00%
Financial Gravity Asset Management, Inc. 63$3230.00%
Truvestments Capital LLC 35$2,2120.00%
SG Americas Securities, LLC 2,179$1380.00%
JANUS HENDERSON GROUP PLC 29,098$1,837,9880.00%
HARBOUR INVESTMENTS, INC. 200$12,6400.00%
NISA INVESTMENT ADVISORS, LLC 2,030$128,2960.00%
Legal & General Group Plc 57,864$3,657,0050.00%
AMERIPRISE FINANCIAL INC 48,145$3,042,7640.00%
LPL Financial LLC 10,936$691,1550.00%
ENVESTNET ASSET MANAGEMENT INC 15,843$1,001,2460.00%
Covestor Ltd 4$00.00%
UBS Group AG 15,000$948,0000.00%
Citadel Advisors 6,500$410,8000.00%
Versant Capital Management, Inc 10$6320.00%
CWM, LLC 416$260.00%
HSBC HOLDINGS PLC 6,202$404,2460.00%
UMB Bank, n.a. 186$11,7550.00%
Cutler Group LLC / CA 56$30.00%
External links

This page lists BLUEPRINT MEDICINES CORP's shareholders in Q2 2023. To view BLUEPRINT MEDICINES CORP's shareholder history, click here.